Berenberg Bank Analysts Give Fresenius SE & Co. KGaA (FRE) a €89.10 Price Target

Berenberg Bank set a €89.10 ($103.60) price target on Fresenius SE & Co. KGaA (FRA:FRE) in a research note released on Tuesday. The brokerage currently has a buy rating on the stock.

Other equities research analysts have also issued research reports about the stock. UBS AG set a €74.00 ($86.05) price target on shares of Fresenius SE & Co. KGaA and gave the stock a neutral rating in a report on Friday, August 18th. The Goldman Sachs Group, Inc. set a €78.00 ($90.70) target price on shares of Fresenius SE & Co. KGaA and gave the stock a neutral rating in a research note on Wednesday, September 20th. Independent Research GmbH set a €94.00 ($109.30) target price on shares of Fresenius SE & Co. KGaA and gave the stock a buy rating in a research note on Tuesday, August 1st. Kepler Capital Markets set a €77.00 ($89.53) target price on shares of Fresenius SE & Co. KGaA and gave the stock a neutral rating in a research note on Wednesday, August 2nd. Finally, S&P Global set a €85.00 ($98.84) target price on shares of Fresenius SE & Co. KGaA and gave the stock a buy rating in a research note on Monday, November 6th. Six investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and an average target price of €81.51 ($94.78).

Shares of Fresenius SE & Co. KGaA (FRE) opened at €63.88 ($74.28) on Tuesday. Fresenius SE & Co. KGaA has a 1-year low of €65.00 ($75.58) and a 1-year high of €80.00 ($93.02).

WARNING: This news story was published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://transcriptdaily.com/2017/11/17/berenberg-bank-analysts-give-fresenius-se-89-10-price-target.html.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co. KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply